0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antimicrobial Peptides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Published Date: June 2024
|
Report Code: QYRE-Auto-15U9080
Home | Market Reports | Health| Pharmacy
Global Antimicrobial Peptides Market Outlook 2022
BUY CHAPTERS

Global Antimicrobial Peptides Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030

Code: QYRE-Auto-15U9080
Report
June 2024
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antimicrobial Peptides Market Size

The global Antimicrobial Peptides market is projected to reach US$ 7 million by 2030 from an estimated US$ 5 million in 2024, at a CAGR of 5.4% during 2024 and 2030.

Antimicrobial Peptides Market

Antimicrobial Peptides Market

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation

Scope of Antimicrobial Peptides Market Report

Report Metric Details
Report Name Antimicrobial Peptides Market
Accounted market size in 2024 an estimated US$ 5 in million
Forecasted market size in 2030 US$ 7 million
CAGR 5.4%
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Plant Antimicrobial Peptides
  • Microbial Antimicrobial Peptides
  • Animal Antimicrobial Peptides
Segment by Application
  • Pharmaceuticals
  • Feed Additives
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology, ProteLight Pharmaceutical & Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Antimicrobial Peptides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antimicrobial Peptides sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Antimicrobial Peptides Market growing?

Ans: The Antimicrobial Peptides Market witnessing a CAGR of 5.4% during the forecast period 2024-2030.

What is the Antimicrobial Peptides Market size in 2030?

Ans: The Antimicrobial Peptides Market size in 2030 will be US$ 7 million.

What is the AnaSpec share in Antimicrobial Peptides Market?

Ans: The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.

What is the Antimicrobial Peptides Market share by region?

Ans: By region, North America had the highest share of sales, at about 35%.

Who are the main players in the Antimicrobial Peptides Market report?

Ans: The main players in the Antimicrobial Peptides Market are AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology, ProteLight Pharmaceutical & Biotechnology

What are the Application segmentation covered in the Antimicrobial Peptides Market report?

Ans: The Applications covered in the Antimicrobial Peptides Market report are Pharmaceuticals, Feed Additives, Others

What are the Type segmentation covered in the Antimicrobial Peptides Market report?

Ans: The Types covered in the Antimicrobial Peptides Market report are Plant Antimicrobial Peptides, Microbial Antimicrobial Peptides, Animal Antimicrobial Peptides

1 Study Coverage
1.1 Antimicrobial Peptides Product Introduction
1.2 Market by Type
1.2.1 Global Antimicrobial Peptides Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Market by Application
1.3.1 Global Antimicrobial Peptides Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antimicrobial Peptides Market Size Estimates and Forecasts
2.1.1 Global Antimicrobial Peptides Revenue 2019-2030
2.1.2 Global Antimicrobial Peptides Sales 2019-2030
2.2 Antimicrobial Peptides Market Size by Region: 2023 Versus 2030
2.3 Antimicrobial Peptides Sales by Region (2019-2030)
2.3.1 Global Antimicrobial Peptides Sales by Region: 2019-2024
2.3.2 Global Antimicrobial Peptides Sales Forecast by Region (2025-2030)
2.3.3 Global Antimicrobial Peptides Sales Market Share by Region (2019-2030)
2.4 Antimicrobial Peptides Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Antimicrobial Peptides Revenue by Region: 2019-2024
2.4.2 Global Antimicrobial Peptides Revenue Forecast by Region (2025-2030)
2.4.3 Global Antimicrobial Peptides Revenue Market Share by Region (2019-2030)
3 Global Antimicrobial Peptides by Manufacturers
3.1 Global Top Antimicrobial Peptides Manufacturers by Sales
3.1.1 Global Antimicrobial Peptides Sales by Manufacturer (2019-2024)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Antimicrobial Peptides Manufacturers by Revenue
3.2.1 Global Antimicrobial Peptides Revenue by Manufacturer (2019-2024)
3.2.2 Global Antimicrobial Peptides Revenue Share by Manufacturer (2019-2024)
3.3 Global Antimicrobial Peptides Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Antimicrobial Peptides Manufacturers Covered: Ranking by Revenue
3.4.2 Global Antimicrobial Peptides Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Antimicrobial Peptides Manufacturing Base Distribution, Product Type
3.5.1 Antimicrobial Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Antimicrobial Peptides Product Type
3.5.3 Date of International Manufacturers Enter into Antimicrobial Peptides Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 AnaSpec
4.1.1 AnaSpec Company Information
4.1.2 AnaSpec Description, Business Overview
4.1.3 AnaSpec Antimicrobial Peptides Products Offered
4.1.4 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.1.5 AnaSpec Antimicrobial Peptides Sales by Product in 2023
4.1.6 AnaSpec Antimicrobial Peptides Sales by Application in 2023
4.1.7 AnaSpec Antimicrobial Peptides Sales by Geographic Area in 2023
4.1.8 AnaSpec Recent Developments
4.2 AMP Biotech
4.2.1 AMP Biotech Company Information
4.2.2 AMP Biotech Description, Business Overview
4.2.3 AMP Biotech Antimicrobial Peptides Products Offered
4.2.4 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.2.5 AMP Biotech Antimicrobial Peptides Sales by Product in 2023
4.2.6 AMP Biotech Antimicrobial Peptides Sales by Application in 2023
4.2.7 AMP Biotech Antimicrobial Peptides Sales by Geographic Area in 2023
4.2.8 AMP Biotech Recent Developments
4.3 Phoenix Biotech
4.3.1 Phoenix Biotech Company Information
4.3.2 Phoenix Biotech Description, Business Overview
4.3.3 Phoenix Biotech Antimicrobial Peptides Products Offered
4.3.4 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Phoenix Biotech Antimicrobial Peptides Sales by Product in 2023
4.3.6 Phoenix Biotech Antimicrobial Peptides Sales by Application in 2023
4.3.7 Phoenix Biotech Antimicrobial Peptides Sales by Geographic Area in 2023
4.3.8 Phoenix Biotech Recent Developments
4.4 Novabiotics
4.4.1 Novabiotics Company Information
4.4.2 Novabiotics Description, Business Overview
4.4.3 Novabiotics Antimicrobial Peptides Products Offered
4.4.4 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Novabiotics Antimicrobial Peptides Sales by Product in 2023
4.4.6 Novabiotics Antimicrobial Peptides Sales by Application in 2023
4.4.7 Novabiotics Antimicrobial Peptides Sales by Geographic Area in 2023
4.4.8 Novabiotics Recent Developments
4.5 Chinese Peptide
4.5.1 Chinese Peptide Company Information
4.5.2 Chinese Peptide Description, Business Overview
4.5.3 Chinese Peptide Antimicrobial Peptides Products Offered
4.5.4 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Chinese Peptide Antimicrobial Peptides Sales by Product in 2023
4.5.6 Chinese Peptide Antimicrobial Peptides Sales by Application in 2023
4.5.7 Chinese Peptide Antimicrobial Peptides Sales by Geographic Area in 2023
4.5.8 Chinese Peptide Recent Developments
4.6 Ontores
4.6.1 Ontores Company Information
4.6.2 Ontores Description, Business Overview
4.6.3 Ontores Antimicrobial Peptides Products Offered
4.6.4 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Ontores Antimicrobial Peptides Sales by Product in 2023
4.6.6 Ontores Antimicrobial Peptides Sales by Application in 2023
4.6.7 Ontores Antimicrobial Peptides Sales by Geographic Area in 2023
4.6.8 Ontores Recent Development
4.7 GenScript
4.7.1 GenScript Company Information
4.7.2 GenScript Description, Business Overview
4.7.3 GenScript Antimicrobial Peptides Products Offered
4.7.4 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.7.5 GenScript Antimicrobial Peptides Sales by Product in 2023
4.7.6 GenScript Antimicrobial Peptides Sales by Application in 2023
4.7.7 GenScript Antimicrobial Peptides Sales by Geographic Area in 2023
4.7.8 GenScript Recent Development
4.8 Hycult Biotech
4.8.1 Hycult Biotech Company Information
4.8.2 Hycult Biotech Description, Business Overview
4.8.3 Hycult Biotech Antimicrobial Peptides Products Offered
4.8.4 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Hycult Biotech Antimicrobial Peptides Sales by Product in 2023
4.8.6 Hycult Biotech Antimicrobial Peptides Sales by Application in 2023
4.8.7 Hycult Biotech Antimicrobial Peptides Sales by Geographic Area in 2023
4.8.8 Hycult Biotech Recent Development
4.9 Sunsmile
4.9.1 Sunsmile Company Information
4.9.2 Sunsmile Description, Business Overview
4.9.3 Sunsmile Antimicrobial Peptides Products Offered
4.9.4 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Sunsmile Antimicrobial Peptides Sales by Product in 2023
4.9.6 Sunsmile Antimicrobial Peptides Sales by Application in 2023
4.9.7 Sunsmile Antimicrobial Peptides Sales by Geographic Area in 2023
4.9.8 Sunsmile Recent Development
4.10 Ruixing Biotechnology
4.10.1 Ruixing Biotechnology Company Information
4.10.2 Ruixing Biotechnology Description, Business Overview
4.10.3 Ruixing Biotechnology Antimicrobial Peptides Products Offered
4.10.4 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Ruixing Biotechnology Antimicrobial Peptides Sales by Product in 2023
4.10.6 Ruixing Biotechnology Antimicrobial Peptides Sales by Application in 2023
4.10.7 Ruixing Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2023
4.10.8 Ruixing Biotechnology Recent Development
4.11 Zhongnong Yingtai Biotechnology
4.11.1 Zhongnong Yingtai Biotechnology Company Information
4.11.2 Zhongnong Yingtai Biotechnology Description, Business Overview
4.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
4.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Product in 2023
4.11.6 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Application in 2023
4.11.7 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2023
4.11.8 Zhongnong Yingtai Biotechnology Recent Development
4.12 Glam Technology
4.12.1 Glam Technology Company Information
4.12.2 Glam Technology Description, Business Overview
4.12.3 Glam Technology Antimicrobial Peptides Products Offered
4.12.4 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.12.5 Glam Technology Antimicrobial Peptides Sales by Product in 2023
4.12.6 Glam Technology Antimicrobial Peptides Sales by Application in 2023
4.12.7 Glam Technology Antimicrobial Peptides Sales by Geographic Area in 2023
4.12.8 Glam Technology Recent Development
4.13 ProteLight Pharmaceutical & Biotechnology
4.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
4.13.2 ProteLight Pharmaceutical & Biotechnology Description, Business Overview
4.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
4.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2019-2024)
4.13.5 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Product in 2023
4.13.6 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Application in 2023
4.13.7 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales by Geographic Area in 2023
4.13.8 ProteLight Pharmaceutical & Biotechnology Recent Development
5 Breakdown Data by Type
5.1 Global Antimicrobial Peptides Sales by Type (2019-2030)
5.1.1 Global Antimicrobial Peptides Sales by Type (2019-2024)
5.1.2 Global Antimicrobial Peptides Sales Forecast by Type (2025-2030)
5.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2019-2030)
5.2 Global Antimicrobial Peptides Revenue Forecast by Type (2019-2030)
5.2.1 Global Antimicrobial Peptides Revenue by Type (2019-2024)
5.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2025-2030)
5.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2019-2030)
5.3 Antimicrobial Peptides Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Antimicrobial Peptides Sales by Application (2019-2030)
6.1.1 Global Antimicrobial Peptides Sales by Application (2019-2024)
6.1.2 Global Antimicrobial Peptides Sales Forecast by Application (2025-2030)
6.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2019-2030)
6.2 Global Antimicrobial Peptides Revenue Forecast by Application (2019-2030)
6.2.1 Global Antimicrobial Peptides Revenue by Application (2019-2024)
6.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2025-2030)
6.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2019-2030)
6.3 Antimicrobial Peptides Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Antimicrobial Peptides Market Size YoY Growth 2019-2030
7.2 North America Antimicrobial Peptides Market Facts & Figures by Country
7.2.1 North America Antimicrobial Peptides Sales by Country (2019-2030)
7.2.2 North America Antimicrobial Peptides Revenue by Country (2019-2030)
7.3 North America Antimicrobial Peptides Sales by Type (2019-2024)
7.4 North America Antimicrobial Peptides Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Antimicrobial Peptides Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Antimicrobial Peptides Market Facts & Figures by Region
8.2.1 Asia-Pacific Antimicrobial Peptides Sales by Region (2019-2030)
8.2.2 Asia-Pacific Antimicrobial Peptides Revenue by Region (2019-2030)
8.3 Asia-Pacific Antimicrobial Peptides Sales by Type (2019-2024)
8.4 Asia-Pacific Antimicrobial Peptides Sales by Application (2019-2024)
9 Europe
9.1 Europe Antimicrobial Peptides Market Size YoY Growth 2019-2030
9.2 Europe Antimicrobial Peptides Market Facts & Figures by Country
9.2.1 Europe Antimicrobial Peptides Sales by Country (2019-2030)
9.2.2 Europe Antimicrobial Peptides Revenue by Country (2019-2030)
9.3 Europe Antimicrobial Peptides Sales by Type (2019-2024)
9.4 Europe Antimicrobial Peptides Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Antimicrobial Peptides Market Size YoY Growth 2019-2030
10.2 Latin America Antimicrobial Peptides Market Facts & Figures by Country
10.2.1 Latin America Antimicrobial Peptides Sales by Country (2019-2030)
10.2.2 Latin America Antimicrobial Peptides Revenue by Country (2019-2030)
10.3 Latin America Antimicrobial Peptides Sales by Type (2019-2024)
10.4 Latin America Antimicrobial Peptides Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Antimicrobial Peptides Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
11.2.1 Middle East and Africa Antimicrobial Peptides Sales by Country (2019-2030)
11.2.2 Middle East and Africa Antimicrobial Peptides Revenue by Country (2019-2030)
11.3 Middle East and Africa Antimicrobial Peptides Sales by Type (2019-2024)
11.4 Middle East and Africa Antimicrobial Peptides Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Antimicrobial Peptides Supply Chain Analysis
12.2 Antimicrobial Peptides Key Raw Materials and Upstream Suppliers
12.3 Antimicrobial Peptides Clients Analysis
12.4 Antimicrobial Peptides Sales Channel and Sales Model Analysis
12.4.1 Antimicrobial Peptides Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Antimicrobial Peptides Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Antimicrobial Peptides Distributors
13 Market Dynamics
13.1 Antimicrobial Peptides Industry Trends
13.2 Antimicrobial Peptides Market Drivers
13.3 Antimicrobial Peptides Market Challenges
13.4 Antimicrobial Peptides Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antimicrobial Peptides Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Major Manufacturers of Plant Antimicrobial Peptides
    Table 3. Major Manufacturers of Microbial Antimicrobial Peptides
    Table 4. Major Manufacturers of Animal Antimicrobial Peptides
    Table 5. Global Antimicrobial Peptides Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2023 VS 2030
    Table 7. Global Antimicrobial Peptides Sales by Region (2019-2024) & (Mg)
    Table 8. Global Antimicrobial Peptides Sales Forecast by Region (2025-2030) & (Mg)
    Table 9. Global Antimicrobial Peptides Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Antimicrobial Peptides Revenue Forecast by Region (2025-2030) & (US$ Million)
    Table 11. Global Antimicrobial Peptides Sales by Manufacturer (2019-2024) & (Mg)
    Table 12. Global Antimicrobial Peptides Sales Share by Manufacturer (2019-2024)
    Table 13. Antimicrobial Peptides Revenue by Manufacturer (2019-2024) & (US$ Million)
    Table 14. Antimicrobial Peptides Revenue Share by Manufacturer (2019-2024)
    Table 15. Key Manufacturers Antimicrobial Peptides Price (2019-2024) & (US$/Mg)
    Table 16. Ranking of Global Top Antimicrobial Peptides Manufacturers by Revenue (US$ Million) in 2023
    Table 17. Global Antimicrobial Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
    Table 18. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2023)
    Table 19. Antimicrobial Peptides Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Antimicrobial Peptides Product Type
    Table 21. Date of International Manufacturers Enter into Antimicrobial Peptides Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. AnaSpec Company Information
    Table 24. AnaSpec Description and Business Overview
    Table 25. AnaSpec Antimicrobial Peptides Product
    Table 26. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 27. AnaSpec Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 28. AnaSpec Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 29. AnaSpec Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 30. AnaSpec Recent Development
    Table 31. AMP Biotech Company Information
    Table 32. AMP Biotech Description and Business Overview
    Table 33. AMP Biotech Antimicrobial Peptides Product
    Table 34. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 35. AMP Biotech Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 36. AMP Biotech Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 37. AMP Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 38. AMP Biotech Recent Development
    Table 39. Phoenix Biotech Company Information
    Table 40. Phoenix Biotech Description and Business Overview
    Table 41. Phoenix Biotech Antimicrobial Peptides Product
    Table 42. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 43. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 44. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 45. Phoenix Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 46. Phoenix Biotech Recent Development
    Table 47. Novabiotics Company Information
    Table 48. Novabiotics Description and Business Overview
    Table 49. Novabiotics Antimicrobial Peptides Product
    Table 50. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 51. Novabiotics Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 52. Novabiotics Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 53. Novabiotics Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 54. Novabiotics Recent Development
    Table 55. Chinese Peptide Company Information
    Table 56. Chinese Peptide Description and Business Overview
    Table 57. Chinese Peptide Antimicrobial Peptides Product
    Table 58. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 59. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 60. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 61. Chinese Peptide Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 62. Chinese Peptide Recent Development
    Table 63. Ontores Company Information
    Table 64. Ontores Description and Business Overview
    Table 65. Ontores Antimicrobial Peptides Product
    Table 66. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 67. Ontores Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 68. Ontores Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 69. Ontores Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 70. Ontores Recent Development
    Table 71. GenScript Company Information
    Table 72. GenScript Description and Business Overview
    Table 73. GenScript Antimicrobial Peptides Product
    Table 74. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 75. GenScript Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 76. GenScript Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 77. GenScript Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 78. GenScript Recent Development
    Table 79. Hycult Biotech Company Information
    Table 80. Hycult Biotech Description and Business Overview
    Table 81. Hycult Biotech Antimicrobial Peptides Product
    Table 82. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 83. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 84. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 85. Hycult Biotech Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 86. Hycult Biotech Recent Development
    Table 87. Sunsmile Company Information
    Table 88. Sunsmile Description and Business Overview
    Table 89. Sunsmile Antimicrobial Peptides Product
    Table 90. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 91. Sunsmile Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 92. Sunsmile Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 93. Sunsmile Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 94. Sunsmile Recent Development
    Table 95. Ruixing Biotechnology Company Information
    Table 96. Ruixing Biotechnology Description and Business Overview
    Table 97. Ruixing Biotechnology Antimicrobial Peptides Product
    Table 98. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 99. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 100. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 101. Ruixing Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 102. Ruixing Biotechnology Recent Development
    Table 103. Zhongnong Yingtai Biotechnology Company Information
    Table 104. Zhongnong Yingtai Biotechnology Description and Business Overview
    Table 105. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
    Table 106. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 107. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 108. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 109. Zhongnong Yingtai Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 110. Zhongnong Yingtai Biotechnology Recent Development
    Table 111. Glam Technology Company Information
    Table 112. Glam Technology Description and Business Overview
    Table 113. Glam Technology Antimicrobial Peptides Product
    Table 114. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 115. Glam Technology Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 116. Glam Technology Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 117. Glam Technology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 118. Glam Technology Recent Development
    Table 119. ProteLight Pharmaceutical & Biotechnology Company Information
    Table 120. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
    Table 121. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
    Table 122. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2019-2024)
    Table 123. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Product in 2023
    Table 124. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Application in 2023
    Table 125. ProteLight Pharmaceutical & Biotechnology Sales Proportion of Antimicrobial Peptides by Geographic Area in 2023
    Table 126. ProteLight Pharmaceutical & Biotechnology Recent Development
    Table 127. Global Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 128. Global Antimicrobial Peptides Sales Forecast by Type (2025-2030) & (Mg)
    Table 129. Global Antimicrobial Peptides Revenue by Type (2019-2024) & (US$ Million)
    Table 130. Global Antimicrobial Peptides Revenue Forecast by Type (2025-2030) & (US$ Million)
    Table 131. Global Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 132. Global Antimicrobial Peptides Sales Forecast by Application (2025-2030) & (Mg)
    Table 133. Global Antimicrobial Peptides Revenue by Application (2019-2024) & (US$ Million)
    Table 134. Global Antimicrobial Peptides Revenue Forecast by Application (2025-2030) & (US$ Million)
    Table 135. North America Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
    Table 136. North America Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
    Table 137. North America Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 138. North America Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 139. North America Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 140. North America Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 141. Asia-Pacific Antimicrobial Peptides Sales by Region (2019-2024) & (Mg)
    Table 142. Asia-Pacific Antimicrobial Peptides Sales by Region (2025-2030) & (Mg)
    Table 143. Asia-Pacific Antimicrobial Peptides Revenue by Region (2019-2030) & (US$ Million)
    Table 144. Asia-Pacific Antimicrobial Peptides Revenue by Region (2025-2030) & (US$ Million)
    Table 145. Asia-Pacific Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 146. Asia-Pacific Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 147. Europe Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
    Table 148. Europe Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
    Table 149. Europe Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 150. Europe Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 151. Europe Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 152. Europe Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 153. Latin America Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
    Table 154. Latin America Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
    Table 155. Latin America Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 156. Latin America Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 157. Latin America Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 158. Latin America Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 159. Middle East and Africa Antimicrobial Peptides Sales by Country (2019-2024) & (Mg)
    Table 160. Middle East and Africa Antimicrobial Peptides Sales by Country (2025-2030) & (Mg)
    Table 161. Middle East and Africa Antimicrobial Peptides Revenue by Country (2019-2024) & (US$ Million)
    Table 162. Middle East and Africa Antimicrobial Peptides Revenue by Country (2025-2030) & (US$ Million)
    Table 163. Middle East and Africa Antimicrobial Peptides Sales by Type (2019-2024) & (Mg)
    Table 164. Middle East and Africa Antimicrobial Peptides Sales by Application (2019-2024) & (Mg)
    Table 165. Antimicrobial Peptides Key Raw Materials, Industry Status and Trend
    Table 166. Antimicrobial Peptides Key Raw Materials and Upstream Suppliers
    Table 167. Antimicrobial Peptides Clients Status and Trend
    Table 168. Antimicrobial Peptides Typical Clients
    Table 169. Antimicrobial Peptides Distributors
    Table 170. Antimicrobial Peptides Market Trends
    Table 171. Antimicrobial Peptides Market Drivers
    Table 172. Antimicrobial Peptides Market Challenges
    Table 173. Antimicrobial Peptides Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antimicrobial Peptides Product Picture
    Figure 2. Global Antimicrobial Peptides Sales Market Share by Type in 2023 & 2030
    Figure 3. Plant Antimicrobial Peptides Product Picture
    Figure 4. Microbial Antimicrobial Peptides Product Picture
    Figure 5. Animal Antimicrobial Peptides Product Picture
    Figure 6. Global Antimicrobial Peptides Sales Market Share by Application in 2023 & 2030
    Figure 7. Pharmaceuticals Examples
    Figure 8. Feed Additives Examples
    Figure 9. Others Examples
    Figure 10. Antimicrobial Peptides Report Years Considered
    Figure 11. Global Antimicrobial Peptides Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Antimicrobial Peptides Market Size 2019-2030 (US$ Million)
    Figure 13. Global Antimicrobial Peptides Sales 2019-2030 (Mg)
    Figure 14. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2019-2030)
    Figure 15. Global Antimicrobial Peptides Revenue Market Share by Region (2019-2030)
    Figure 16. Global Antimicrobial Peptides Sales Share by Manufacturer in 2023
    Figure 17. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 18. Global Antimicrobial Peptides Sales Market Share Forecast by Type (2019-2030)
    Figure 19. Global Antimicrobial Peptides Revenue Market Share Forecast by Type (2019-2030)
    Figure 20. Antimicrobial Peptides Average Selling Price (ASP) by Type (2019-2024) & (US$/Mg)
    Figure 21. Global Antimicrobial Peptides Sales Market Share Forecast by Application (2019-2030)
    Figure 22. Global Antimicrobial Peptides Revenue Market Share Forecast by Application (2019-2030)
    Figure 23. Antimicrobial Peptides Average Selling Price (ASP) by Application (2019-2024) & (US$/Mg)
    Figure 24. North America Antimicrobial Peptides Revenue 2019-2030 (US$ Million)
    Figure 25. North America Antimicrobial Peptides Sales Market Share by Type (2019-2024)
    Figure 26. North America Antimicrobial Peptides Sales Market Share by Application (2019-2024)
    Figure 27. Asia-Pacific Antimicrobial Peptides Revenue 2019-2030 (US$ Million)
    Figure 28. Asia-Pacific Antimicrobial Peptides Sales Market Share by Region (2019-2030)
    Figure 29. Asia-Pacific Antimicrobial Peptides Revenue Market Share by Region (2019-2030)
    Figure 30. Asia-Pacific Antimicrobial Peptides Sales Market Share by Type (2019-2024)
    Figure 31. Asia-Pacific Antimicrobial Peptides Sales Market Share by Application (2019-2024)
    Figure 32. Europe Antimicrobial Peptides Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 33. Europe Antimicrobial Peptides Sales Market Share by Country (2019-2030)
    Figure 34. Europe Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
    Figure 35. Europe Antimicrobial Peptides Sales Market Share by Type (2019-2024)
    Figure 36. Europe Antimicrobial Peptides Sales Market Share by Application (2019-2024)
    Figure 37. Latin America Antimicrobial Peptides Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 38. Latin America Antimicrobial Peptides Sales Market Share by Country (2019-2030)
    Figure 39. Latin America Antimicrobial Peptides Revenue Market Share by Country (2019-2024)
    Figure 40. Latin America Antimicrobial Peptides Sales Market Share by Type (2019-2024)
    Figure 41. Latin America Antimicrobial Peptides Sales Market Share by Application (2019-2024)
    Figure 42. Middle East and Africa Antimicrobial Peptides Revenue Growth Rate 2019-2030 (US$ Million)
    Figure 43. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2019-2030)
    Figure 44. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2019-2030)
    Figure 45. Middle East and Africa Antimicrobial Peptides Sales Market Share by Type (2019-2024)
    Figure 46. Middle East and Africa Antimicrobial Peptides Sales Market Share by Application (2019-2024)
    Figure 47. Antimicrobial Peptides Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Antimicrobial Peptides Raw Materials by Region in 2023
    Figure 49. Antimicrobial Peptides Distribution Channels
    Figure 50. Global Antimicrobial Peptides Percentage 2019-2030: Indirect Sales VS Direct Sales
    Figure 51. Global Antimicrobial Peptides Percentage 2019-2030: Online Sales VS Offline Sales
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pseudobulbar Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11M17013
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart